In this special webinar, Dr. Steven Deeks (Professor of Medicine-in-Residence at the University of California, San Francisco) will be hosted by Solve M.E. Medical Advisor Dr. David Hardy (former Director of Division of Infectious Diseases at Cedars-Sinai Medical Center, Los Angeles, and Professor of Medicine at David Geffen School of Medicine, University of California, Los […]
Hosting EmPOWER M.E. during Advocacy Week each year is one of our favorite ways to connect with our community after a long week of congressional meetings. This year, our Lived Experience Taskforce (LET) partners helped us choose our topic: Navigating the World with Energy Limiting Disabilities. This special event on April 21 at 10 AM […]
The US Food and Drug Administration (FDA) is hosting a virtual public meeting on Patient-Focused Drug Development for Long Covid on Tuesday, April 25th, 2023, from 10 a.m. to 4:00 p.m. ET. It will be conducted with live translation in both English and Spanish. Patient-Focused Drug Development meetings are important and infrequent opportunities for patients to provide […]
Many individuals who have had COVID-19 experience long-term symptoms that have a major impact on their lives. One of the most common symptoms is sleep disturbance. After more than six months from the time of infection, about 60% of people self-report lingering sleep difficulties, even if they had a mild course of acute COVID-19. Unrefreshing […]
The Institute for Neuro Immune Medicine will host the conference in the Alan B. Levan Innovation Center on the Nova Southeastern University campus in Davie, FL May 19th 12:30 – 5pm The goal of the conference is to highlight new information, present ongoing research and new services being offered in their clinic. Among the topics to […]
Solve M.E. is excited to host STAT Health CEO Daniel Lee for a conversation about their innovative in-ear wearable device. We'll discuss how the STAT in-ear wearable measures blood flow to the head, tracks changes in heart rate and blood pressure trend when users stand up. Designed to empower individuals with ME/CFS, Long Covid, and […]
Mark your calendars July 27 - 29, 2023 for the IACFS/ME's International Scientific Conference to be held at Stony Brook University in Stony Brook, New York, USA. This will be their 16th Scientific Conference! Program will include: Research presentations Innovative symposia Clinical workshops Poster sessions Suggestions on possible topics, speakers, workshops or organizations should be sent […]
Tomorrow's NINDS ME/CFS Research Roadmap webinar at 11AM ET will focus on how ME/CFS impacts the immune system, current research, knowledge gaps, and future research opportunities. Register here. A recording of the first session, focusing on the nervous system, is available here.
Solve welcomes three medical providers who will share their experience with treating Long Covid, ME/CFS, POTS, and dysautonomia patients across rural, urban, and suburban settings. Dr. Melanie Hoppers (co-founder and Chief Medical Officer at Physicians Quality Care, in Jackson, TN), Dr. William Pittman (co-director of the UCLA Long COVID Program), and Dr. Tiffany Walker (Principal […]
NIH ME/CFS Research Roadmap Webinar Series August - December 2023 This virtual webinar series is part of a larger effort to develop a Research Roadmap for ME/CFS, which will identify research priorities to move the field toward translational studies and clinical trials. Save the date for two NIH ME/CFS events in December 2023! Additional details will be […]
Free radicals are molecules with one or more unpaired electrons in their outer shells. They tear holes in cell membranes, releasing an overabundance of even more free radicals and preventing proper cell functionality. Antioxidants are molecules stable enough to donate an electron to a rampaging free radical and neutralize it, containing the damage it […]
Join us for a webinar on April 29 from 3-4 pm PT / 6-7 pm ET with Solve Ramsay Research Grant winners Liisa K. Selin, MD, PhD, and Anna Gil, PhD (viral immunologists from the Univ. of Massachusetts Chan Medical School), Roshan Kumar, PhD (clinical stage global biotech company HiFiBiO Therapeutics), and the labs' patient […]
